KIERSTEN HOGG: Open Payments
NPI 1821566316 · ONTARIO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 88 payments from 14 companies in 2025. Trend: 2023 $578 · 2024 $1,339 · 2025 $2,105
Food & beverage: $1,954Education: $151
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $440 |
| Teva Pharmaceuticals USA, Inc. | 17 | $414 |
| Neurocrine BioSciences, Inc. | 19 | $347 |
| Axsome Therapeutics, Inc. | 6 | $187 |
| Vanda Pharmaceuticals Inc. | 12 | $161 |
| E.R. Squibb & Sons, L.L.C. | 6 | $159 |
| ABBVIE INC. | 1 | $119 |
| Alkermes, Inc. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Neuronetics, Inc. | 1 | $34 |
Products named: INGREZZA, REXULTI, Auvelity, FANAPT, COBENFY, AUSTEDO XR, VRAYLAR, ABILIFY MAINTENA.
Industry payments across OR — which companies pay providers there.
